Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

FDA Expands Empagliflozin Heart Failure Indication.

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/drug therapy

  • Source: JAMA [JAMA] 2022 Apr 05; Vol. 327 (13), pp. 1219.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Using Insulin to Treat Poorly Controlled Type 2 Diabetes in 2020.

Subjects: Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Hypoglycemic Agents/Hypoglycemic Agents/Hypoglycemic Agents/*therapeutic use ; Insulin/Insulin/Insulin/*therapeutic use

  • Source: JAMA [JAMA] 2020 Jun 16; Vol. 323 (23), pp. 2419-2420.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Explaining variations in hospital death rates. Randomness, severity of illness, quality of care.

  • Authors : Park RE; Health Sciences Program, RAND Corporation, Santa Monica, CA 90406.; Brook RH

Subjects: Health Services Research* ; Mortality* ; Severity of Illness Index*

  • Source: JAMA [JAMA] 1990 Jul 25; Vol. 264 (4), pp. 484-90.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Geographic variation in diagnosis frequency and risk of death among Medicare beneficiaries.

  • Authors : Welch HG; Department of Veterans Affairs Medical Center, White River Junction, Vermont, USA. ; Sharp SM

Subjects: Diagnosis*; Chronic Disease/Chronic Disease/Chronic Disease/*mortality ; Medicare/Medicare/Medicare/*statistics & numerical data

  • Source: JAMA [JAMA] 2011 Mar 16; Vol. 305 (11), pp. 1113-8.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

  • Authors : Nissen SE; Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA. ; Wolski K

Subjects: Cardiovascular Diseases/Cardiovascular Diseases/Cardiovascular Diseases/*mortality ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*drug therapy ; Glycine/Glycine/Glycine/*analogs & derivatives

  • Source: JAMA [JAMA] 2005 Nov 23; Vol. 294 (20), pp. 2581-6. Date of Electronic Publication: 2005 Oct 20.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model:

Record details

×
Academic Journal

Risk factors for 5-year mortality in older adults: the Cardiovascular Health Study.

  • Authors : Fried LP; Department of Medicine, The Johns Hopkins Medical Institutions, Baltimore, Md, USA.; Kronmal RA

Subjects: Mortality*; Black or African American/Black or African American/Black or African American/statistics & numerical data ; Aged

  • Source: JAMA [JAMA] 1998 Feb 25; Vol. 279 (8), pp. 585-92.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
Academic Journal

Assessing hospital-associated deaths from discharge data. The role of length of stay and comorbidities.

  • Authors : Jencks SF; Office of Research, Health Care Financing Administration, Baltimore.; Williams DK

Subjects: Hospitals* ; Mortality* ; Patient Discharge*

  • Source: JAMA [JAMA] 1988 Oct 21; Vol. 260 (15), pp. 2240-6.Publisher: American Medical Association Country of Publication: United States NLM ID: 7501160 Publication Model: Print Cited

Record details

×
  • 1-8 of  8 results for ""Heart Failure""